NO880935L - Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning. - Google Patents

Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.

Info

Publication number
NO880935L
NO880935L NO88880935A NO880935A NO880935L NO 880935 L NO880935 L NO 880935L NO 88880935 A NO88880935 A NO 88880935A NO 880935 A NO880935 A NO 880935A NO 880935 L NO880935 L NO 880935L
Authority
NO
Norway
Prior art keywords
hiv
virus
discussion
procedure
clinical effect
Prior art date
Application number
NO88880935A
Other languages
English (en)
Norwegian (no)
Other versions
NO880935D0 (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO880935D0 publication Critical patent/NO880935D0/no
Publication of NO880935L publication Critical patent/NO880935L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO88880935A 1987-12-23 1988-03-02 Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning. NO880935L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13697887A 1987-12-23 1987-12-23

Publications (2)

Publication Number Publication Date
NO880935D0 NO880935D0 (no) 1988-03-02
NO880935L true NO880935L (no) 1989-06-26

Family

ID=22475294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88880935A NO880935L (no) 1987-12-23 1988-03-02 Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.

Country Status (17)

Country Link
EP (1) EP0325018A3 (ru)
JP (1) JP2690493B2 (ru)
KR (1) KR890010562A (ru)
CN (1) CN1043569A (ru)
AU (2) AU1256488A (ru)
CA (1) CA1337277C (ru)
DK (1) DK112988A (ru)
FI (1) FI880960A (ru)
HU (1) HU205460B (ru)
IL (1) IL85577A0 (ru)
NO (1) NO880935L (ru)
OA (1) OA08815A (ru)
PH (1) PH25365A (ru)
PT (1) PT86880B (ru)
RU (1) RU1836101C (ru)
SU (1) SU1687035A3 (ru)
ZA (1) ZA881470B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278042A (en) * 1989-02-06 1994-01-11 The United States Of America As Represented By The Department Of Health & Human Services Method for detecting inhibitors of tat protein
FR2725214A1 (fr) * 1994-09-30 1996-04-05 Inst Nat Sante Rech Med Nouveaux composes utilisables pour la preparation d'agents anti-infectieux
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
NZ547283A (en) 1998-03-20 2008-06-30 Commw Scient Ind Res Org Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (en) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
CN112088903A (zh) * 2020-09-28 2020-12-18 武汉愔紫生物科技有限公司 一种大分子蛋白在抗菌抗病毒消毒剂中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505845A1 (fr) * 1981-05-13 1982-11-19 Choay Sa Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
JPH01171500A (ja) 1989-07-06
PT86880B (pt) 1993-01-29
KR890010562A (ko) 1989-08-09
CN1043569A (zh) 1990-07-04
ZA881470B (en) 1988-11-18
CA1337277C (en) 1995-10-10
HUT47745A (en) 1989-03-28
DK112988D0 (da) 1988-03-02
PH25365A (en) 1991-05-13
AU660973B2 (en) 1995-07-13
PT86880A (pt) 1988-04-01
EP0325018A2 (en) 1989-07-26
HU205460B (en) 1992-04-28
IL85577A0 (en) 1988-08-31
OA08815A (en) 1989-03-31
JP2690493B2 (ja) 1997-12-10
EP0325018A3 (en) 1990-01-17
AU1618792A (en) 1992-09-10
DK112988A (da) 1989-06-24
AU1256488A (en) 1989-06-29
FI880960A0 (fi) 1988-03-02
FI880960A (fi) 1989-06-24
NO880935D0 (no) 1988-03-02
RU1836101C (ru) 1993-08-23
SU1687035A3 (ru) 1991-10-23

Similar Documents

Publication Publication Date Title
NO885106L (no) Fremgangsmaate ved fremstilling av cytidin-derivater.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO873822D0 (no) Framgangsmaate for tilvirkning av keramiske kompositter.
NO159274C (no) Analogifremgangsmaate for fremstilling av fenyl-alifatisk-isoksazoler for bekjempelse av virus.
NO880262D0 (no) Fremgangsmaate for fremstilling av b avermectiner.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO880935D0 (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
NO883392D0 (no) Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater.
NO873824D0 (no) Framgangsmaate for tilvirkning av keramiske kompositter.
NO861189L (no) Fremgangsmaate for fremstilling av alfa-l-aspartyl-l-fenylalanin-methylester eller hydroklorid derav.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
NO873400L (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO871759L (no) Fremgangsmaate for fremstilling av sucralfatpreparater.
NO873727L (no) Fremgangsmaate for fremstilling av benzoksazoninforbindelser med terapeutisk aktivitet.
NO863434D0 (no) Fremgangsmaate for fremstilling av metylendioksyfenantren- og stilbenderivater.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO872690D0 (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO920080D0 (no) Fremgangsmaate ved fremstilling av proteiner med fviii aktivitet og/eller fviii derivater
NO885446D0 (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
NO872199D0 (no) Analogifremgangsmaate for fremstilling av alkoxyalkyl- og alkylmercaptoalkylsubstituerte benzofuroisokinoliner.
NO862126L (no) Fremgangsmaate ved fremstilling av deutrert akrylsyre eller deutrert metakrylsyre.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
NO874698D0 (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.